MDM2 and cancer: Several clinicopathological parameters, including sample type, cancer stage, ethnicity, gender, body mass index, age, histopathologic subtype, and TP53 mutation status were found to correlate highly with MDM2 gene overexpression in “TCGA” brain tissues, as measured by mRNA expression.